Tag: EXAD

Blue Horseshoe Stocks: EXAD Review, Options & More

Experience Art & Design, Inc. EXAD – Impressive Run Continues

Yesterday morning, we were just updating readers on the call we made last Monday on EXAD at a low of .0009. It had subsequently run up to a high of .0024 (+167%) and we were congratulating folks who latched on for a nice profit.

We went on to mention that the stock was “exhibiting momentum-play characteristics” and that we’d continue to be interested if it could maintain support above .0015 on any pullbacks. Ultimately, there was no pullback. EXAD opened at Friday’s high and closing price of .0024, and took off on another bullish session that took it to an impressive new high of .0039; an intraday pop of 62%.

It closed at its high for the second straight session, and pushed our overall observed range in just a week’s time to 333%  As long as the stock continues to register higher base levels of support, we’ll remain interested in what has concisely demonstrated itself to be an extreme momentum-mover!

Shire plc SHPG – Options Idea

We also want to follow up on our options trading idea that we floated in yesterday’s premarket report, the SHPG Weekly $175-180 Calls. We said that we’d have them on watch throughout the course of the week, and would just like to reiterate that this morning.

We’re seeing a notable gap-up in early trading to day that should begin to fuel healthy observed gains for our highlighted contracts.


ChromaDex Corp CDXC

We have an interesting little story that has unfolded for CDXC inside of the past 24 hours. Yesterday a report and “Shareholder Alert” was published that effected a steep decline which you can very plainly see on the included chart.

Frank L. Jaksch, CEO of ChromaDex immediately responded, alleging that “The report appears to be a blatant and transparent attempt by a shortseller or shortsellers to profit from an immediate and precipitous decline in the company’s share price through the use of an opinion piece published anonymously and laden with misinformation…”

Even if the report contained elements of truth, the sharp selloff which occurred yesterday seems to be an over-reaction. We’ll have CDXC on recovery watch in coming sessions.

Extended Watchlist:
ELED, BHGI, RVUE, FTEK,
CUR(Gap to fill to .55)

Blue Horseshoe Stocks: EXAD Recap & More

Experience Art & Design, Inc. EXAD – Update

We began tracking EXAD off of its bottom at the beginning of last week, at which time we observed a low of .0009 in the stock. We were pleased with its steady albeit limited progress throughout the course of the week as it registered higher lows each day.

Then on Friday, the uptrend really kicked into high gear as we observed an impressive daily trading range from the open at its low of .001 to the close at it high of .0024. That worked out to a 140% intraday swing, and an overall increase of 167% over our observed low on Monday.

With the stock exhibiting momentum-play characteristics, we’ll certainly want to leave a slot open for it on our radar as we kick off a new trading week. In order to hold our interest, EXAD will need to maintain support at or above .0015 on any consolidations.

Shire plc SHPG – Options Idea

We’re intrigued with the present situation on SHPG, a stock whose options chain provided us with multi-bag opportunities from an idea we submitted early this year. Last week, the company made headlines as one of their drugs received FDA approval for an expanded label (Link to PR below), and this morning, we’re seeing a notable gap-up occurring in premarket trading this morning.

We’re going to look into using the current situation to our advantage by monitoring a series of options calls. Our target range is going to be the SHPG Weekly $175-180 Calls. We’ll have these on watch throughout the course of the week.

Extended Watchlist:
ESDI, SOUP, GST, PUK, SDRL, TCK

Blue Horseshoe Stocks: EBIO, HRB Updates & More

H&R Block, Inc. HRB – Options Update

The options idea we formulated and passed along to our readers on Friday for HRB was far away our best play of the week, and an excellent way to wrap it up. Our specific target range that we highlighted in this case was the HRB 06/17 $21-23 Calls. and we ended up seeing monstrous moves out of each of the contained contracts.

$21 Calls – Trading Range: .60-3.30 – Max Gain: 450%
$22 Calls – Trading Range: .15-2.30 – Max Gain: 1430%
$23 Calls– Trading Range: .05-1.30 – Max Gain: 2500%

______

Added Reminder:

The other options play we set our sights on in Friday morning’s report was Global Blood Therapeutics,Inc. GBT – 06/17 $20-30 Calls. We saw some moderate activity as the stock ran early in the day, before tapering off. As they don’t expire until the end of this week, we just wanted to reiterate the possibility of more pronounced moves if GBT maintains support at 22.00 or above.

Eleven Biotherapeutics, Inc. EBIO 

The last time we reminded folks about our interest in EBIO, a stock that has appeared in our reports many times in the past, was on June 3rd. On that day, we were commenting on an earlier alert we put out on it back in May while EBIO’s PPS was at .80, after seeing it run up to its then-high of 2.10.

It ended up topping out at 2.60 on the afternoon of the 3rd, and has since been under light consolidation. It reached a support level of 1.62 on Friday, before beginning to rebound, and this morning it has gapped up hard in the premarket to a new high of 3.55 on the strength of an attractive PR (link below).

From our observed low in May, it represents an overall increase of 344% We’ll want to see the stock’s previous resistance level of 2.60 hold as support on any early pullbacks.

Extended Watchlist:
AROPQ, EXAD, TRQ, GIG, AMRS, QURE,
FLXN(Big Insider Buying)

Get Our FREE Daily Reports!

SUBSCRIBE